FDA
approval
· 2018-01-26
FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Original Application (Cipla USA Inc.)
Summary
FDA approved the original generic application for tenofovir disoproxil fumarate (Cipla USA Inc.), enabling a generic version of the HIV and hepatitis B therapy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIR DISOPROXIL FUMARATE)